Actionable news
0
All posts from Actionable news
Actionable news in ZSPH: ZS PHARMA Inc,

ZS Pharma (ZSPH) Stock Gets Rating Downgrade at Credit Suisse

NEW YORK (TheStreet) -- ZS Pharma (ZSPH) stock was downgraded to "neutral" from "outperform" at Credit Suisse this morning.

The firm raised its price target to $90 from $67 on the stock.

On Friday, the biopharmaceutical company agreed to be acquired by AstraZeneca (AZN) for $90 per share, or roughly $2.7 billion.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks with serious upside potential in...


More